Ciffformula (Cifformulanew)
Revesta
Product Images NDC 69336-330
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revesta (NDC 69336-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sterling Knight Pharmaceuticals,llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Revesta (Revesta)
This is a description of a medication called Revesta. It is available in the form of capsules which are taken orally with or without food. The usual adult dosage for this medication is one capsule per day. Revesta should be taken under the supervision of a licensed medical practitioner. Pregnant or nursing women should consult a health professional before using this medication. The manufacturing facility also manufactures products containing fish, egg, wheat, soy, and shellfish. The medication should be kept out of reach of children. Any side effects should be reported to a doctor or to the FDA. The medication is a prescription vitamin for dietary management of patients with unique nutritional needs. Each capsule contains 1mg of Cholecalciferol. The medication is only available under physician's supervision. Gelatin, water, soybean oil, and other ingredients are used to manufacture the capsules. Storage should be done at 25°C. There is no therapeutic equivalence claim for this product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
